BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28974895)

  • 61. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.
    Yang SH; Guo JC; Yeh KH; Tien YW; Cheng AL; Kuo SH
    J Gastroenterol Hepatol; 2016 Dec; 31(12):2004-2012. PubMed ID: 27059987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation of body mass index to outcome in patients with known or suspected coronary artery disease.
    Galal W; van Domburg RT; Feringa HH; Schouten O; Elhendy A; Bax JJ; Awara AM; Klein J; Poldermans D
    Am J Cardiol; 2007 Jun; 99(11):1485-90. PubMed ID: 17531566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
    Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
    Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
    Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
    Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.
    Hayashi Y; Correa AM; Hofstetter WL; Vaporciyan AA; Mehran RJ; Rice DC; Suzuki A; Lee JH; Bhutani MS; Welsh J; Lin SH; Maru DM; Swisher SG; Ajani JA
    Dis Esophagus; 2012; 25(7):614-22. PubMed ID: 22150920
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
    Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
    Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.
    Su TS; Liang P; Lu HZ; Liang JN; Liu JM; Zhou Y; Gao YC; Tang MY
    World J Gastroenterol; 2015 Jul; 21(26):8156-62. PubMed ID: 26185389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
    Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
    Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relation of Body Mass Index to Long-Term Survival After Cardiac Resynchronization Therapy.
    Grandin EW; Wand A; Zamani P; Rame JE; Verdino RJ
    Am J Cardiol; 2016 Dec; 118(12):1861-1867. PubMed ID: 27823599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.
    Kasenda B; Bass A; Koeberle D; Pestalozzi B; Borner M; Herrmann R; Jost L; Lohri A; Hess V
    BMC Cancer; 2014 Sep; 14():728. PubMed ID: 25266049
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
    Toriola AT; Luo S; Thomas TS; Drake BF; Chang SH; Sanfilippo KM; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):169-175. PubMed ID: 31685560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan.
    Okura T; Fujii M; Shiode J; Ito Y; Kojima T; Nasu J; Niguma T; Yoshioka M; Mimura T; Yamamoto K
    Acta Med Okayama; 2018 Apr; 72(2):129-135. PubMed ID: 29674761
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.